Trade Citius Pharmaceuticals, Inc. - CTXR CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0136 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023457% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001235% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 0.9907 |
| Open | 0.9744 |
| 1-Year Change | 29.28% |
| Day's Range | 0.9624 - 0.9787 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 15, 2025 | 0.9907 | 0.0120 | 1.23% | 0.9787 | 1.0087 | 0.9787 |
| Apr 14, 2025 | 0.9787 | 0.0300 | 3.16% | 0.9487 | 0.9887 | 0.9487 |
| Apr 11, 2025 | 0.9385 | -0.0602 | -6.03% | 0.9987 | 0.9987 | 0.9223 |
| Apr 10, 2025 | 0.9587 | -0.0500 | -4.96% | 1.0087 | 1.0087 | 0.9387 |
| Apr 9, 2025 | 1.0287 | 0.0600 | 6.19% | 0.9687 | 1.0387 | 0.9587 |
| Apr 8, 2025 | 0.9687 | -0.1200 | -11.02% | 1.0887 | 1.0887 | 0.9687 |
| Apr 7, 2025 | 1.0487 | 0.1000 | 10.54% | 0.9487 | 1.0487 | 0.9487 |
| Apr 4, 2025 | 0.9987 | 0.0000 | 0.00% | 0.9987 | 1.0187 | 0.9587 |
| Apr 3, 2025 | 1.0187 | -0.1300 | -11.32% | 1.1487 | 1.1487 | 0.9847 |
| Apr 2, 2025 | 1.1687 | -0.0300 | -2.50% | 1.1987 | 1.1987 | 1.1487 |
| Apr 1, 2025 | 1.1887 | -0.0800 | -6.31% | 1.2687 | 1.3187 | 1.1787 |
| Mar 31, 2025 | 1.4687 | -0.1300 | -8.13% | 1.5987 | 2.2687 | 1.3887 |
| Mar 28, 2025 | 1.5387 | 0.2700 | 21.28% | 1.2687 | 1.6687 | 1.2487 |
| Mar 27, 2025 | 1.2687 | -0.0800 | -5.93% | 1.3487 | 1.3487 | 1.1987 |
| Mar 26, 2025 | 1.3587 | -0.0900 | -6.21% | 1.4487 | 1.4487 | 1.3287 |
| Mar 25, 2025 | 1.4687 | -0.0700 | -4.55% | 1.5387 | 1.5387 | 1.3887 |
| Mar 24, 2025 | 1.5487 | 0.0000 | 0.00% | 1.5487 | 1.5687 | 1.5087 |
| Mar 21, 2025 | 1.5187 | -0.0300 | -1.94% | 1.5487 | 1.5487 | 1.4987 |
| Mar 20, 2025 | 1.5487 | -0.0500 | -3.13% | 1.5987 | 1.5987 | 1.5487 |
| Mar 19, 2025 | 1.6087 | 0.0400 | 2.55% | 1.5687 | 1.6587 | 1.5687 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Citius Pharmaceuticals, Inc. Company profile
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic lock solution for treating patients with catheter-related bloodstream infections by salvaging the infected catheter; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a corticosteroid-lidocaine topical formulation that intends to provide anti-inflammatory and anesthetic relief to persons suffering with hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome; and I/ONTAK, a engineered IL-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.| Industry: | Biotechnology & Medical Research (NEC) |
11 Commerce Dr Fl 1
CRANFORD
NEW JERSEY 07016-3501
US
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com